| Financier | Commitments |
|---|---|
| International Bank for Reconstruction and Development | 120.00 |
Tunisia COVID-19 Response project
Abstract*
This operation is being prepared as an emergency response using condensed procedures under the Fast Track COVID-19 Facility (FTCF).
On March 2, 2020, the Government of Tunisia (GoT) confirmed its first case of COVID-19. By April 3, 2020, the number of confirmed cases had risen to 495 and 14 deaths have been reported. The GoT adopted measures to contain the spread of the virus, including suspension of all international flights, closing its borders... Show More
Development Objective
To prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness.
Key Details
Project Details
P173945
Active
Yassine Kalboussi , Fatima El Kadiri El Yamani
Republic of Tunisia,Ministry of Health
April 23, 2020
(as of board presentation)
April 30, 2020
June 1, 2020
US$ 120.00 million
Ministry of Health
2020
US$ 120.00 million
N/A
Moderate
December 31, 2025
Yes
BANK APPROVED
May 24, 2024
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | 120.00 |
| IDA Commitment | N/A |
| IBRD + IDA Commitment | 120.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 120.00 |
Summary Status of World Bank Financing (US$ Millions) as of April 30, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Dec 30, 2021 | IBRD-92230 | Loan Disb | 23,709,074.00 |
| Mar 14, 2022 | IBRD-92230 | Loan Disb | 12,942,144.00 |
| Nov 1, 2020 | IBRD-91120 | Int Charges | 41,529.21 |
| Nov 1, 2021 | IBRD-92230 | Int Charges | 36,112.78 |
| May 1, 2021 | IBRD-91120 | Int Charges | 19,011.50 |
| Apr 22, 2021 | IBRD-91120 | Loan Disb | -22,052,416.00 |
| May 26, 2021 | IBRD-92230 | Loan Disb | 252,429.38 |
| May 26, 2021 | IBRD-92230 | Fee Charges | 252,429.38 |
| Jun 25, 2021 | IBRD-92230 | Loan Disb | 23,892,000.00 |
| Jun 22, 2020 | IBRD-91120 | Loan Disb | 20,470,316.00 |
| Jun 1, 2020 | IBRD-91120 | Loan Disb | 50,809.95 |
| Jun 1, 2020 | IBRD-91120 | Fee Charges | 50,809.95 |
| Nov 1, 2023 | IBRD-91120 | Int Charges | 78,616.10 |
| Nov 1, 2023 | IBRD-91120 | Loan Repay | 804,928.44 |
| May 1, 2022 | IBRD-91120 | Int Charges | 82,169.29 |
| Nov 1, 2022 | IBRD-91120 | Int Charges | 77,285.02 |
| Apr 30, 2020 | IBRD-91120 | Loan Commitment | 20,000,000.00 |
| Mar 26, 2021 | IBRD-92230 | Loan Commitment | 100,000,000.00 |
| May 24, 2022 | IBRD-94110 | Loan Commitment | 22,000,000.00 |
| Nov 15, 2023 | IBRD-94110 | Int Charges | 354,537.47 |
| May 15, 2024 | IBRD-94110 | Int Charges | 18.20 |
| May 15, 2024 | IBRD-94110 | Int Charges | 544,703.56 |
| Jun 12, 2023 | IBRD-94110 | Loan Disb | 9,574,018.00 |
| Aug 8, 2023 | IBRD-94110 | Loan Disb | 8,749,618.00 |
| Aug 25, 2023 | IBRD-94110 | Loan Disb | 3,850,166.20 |
| Nov 30, 2023 | IBRD-94110 | Loan Disb | 446,596.50 |
| May 15, 2023 | IBRD-94110 | Int Charges | 34.36 |
| May 15, 2023 | IBRD-94110 | Int Charges | 19,755.40 |
| Mar 7, 2023 | IBRD-94110 | Loan Disb | 3,197,100.00 |
| Aug 3, 2023 | IBRD-94110 | Loan Disb | -3,293,700.00 |
| Oct 12, 2022 | IBRD-94110 | Loan Disb | 50,766.10 |
| Oct 12, 2022 | IBRD-94110 | Fee Charges | 50,766.10 |
| Jun 18, 2024 | IBRD-92230 | Loan Disb | 20,396,406.00 |
| May 1, 2024 | IBRD-92230 | Int Charges | 28,040.01 |
| May 1, 2024 | IBRD-92230 | Int Charges | 1,675,167.90 |
| May 1, 2024 | IBRD-92230 | Int Charges | 5,662.12 |
| Apr 14, 2023 | IBRD-92230 | Loan Disb | 214,866.98 |
| Nov 1, 2022 | IBRD-92230 | Int Charges | 6,570.80 |
| Nov 1, 2022 | IBRD-92230 | Int Charges | 7,241.67 |
| May 1, 2023 | IBRD-91120 | Int Charges | 85,626.39 |
| May 1, 2023 | IBRD-91120 | Loan Repay | 840,146.00 |
| Apr 22, 2021 | IBRD-91120 | Loan Disb | 22,052,416.00 |
| Nov 1, 2021 | IBRD-91120 | Int Charges | 3,546.95 |
| Nov 1, 2021 | IBRD-91120 | Int Charges | 89,997.34 |
| Nov 1, 2021 | IBRD-91120 | Int Charges | 952.91 |
| May 1, 2024 | IBRD-91120 | Int Charges | 76,057.79 |
| May 1, 2024 | IBRD-91120 | Loan Repay | 814,162.06 |
| Nov 1, 2022 | IBRD-92230 | Int Charges | 190,920.30 |
| Jun 20, 2023 | IBRD-92230 | Loan Disb | 241,189.27 |
| Aug 30, 2023 | IBRD-92230 | Loan Disb | 2,163,855.20 |
| May 1, 2023 | IBRD-92230 | Int Charges | 873,339.50 |
| May 1, 2023 | IBRD-92230 | Int Charges | 40,314.30 |
| May 1, 2022 | IBRD-92230 | Int Charges | 76,554.01 |
| May 1, 2024 | IBRD-92230 | Int Charges | 322.93 |
| Jun 26, 2024 | IBRD-92230 | Loan Disb | 2,083,397.90 |
| Nov 1, 2023 | IBRD-92230 | Int Charges | 23.86 |
| Nov 1, 2023 | IBRD-92230 | Int Charges | 264.55 |
| Nov 1, 2023 | IBRD-92230 | Int Charges | 34,441.13 |
| Nov 1, 2023 | IBRD-92230 | Int Charges | 1,388,371.90 |
| Oct 5, 2023 | IBRD-92230 | Loan Disb | 1,721,635.60 |
| Nov 30, 2023 | IBRD-92230 | Loan Disb | -446,596.50 |
| Aug 4, 2023 | IBRD-92230 | Loan Disb | 4,862,030.00 |
| Jun 16, 2023 | IBRD-92230 | Loan Disb | 324,788.60 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Procurement | Satisfactory | 2025-01-16 |
| Financial Management | Moderately Satisfactory | 2025-01-16 |
| Project Management | Satisfactory | 2025-01-16 |
| Progress towards achievement of PDO | Satisfactory | 2025-01-16 |
| Monitoring and Evaluation | Satisfactory | 2025-01-16 |
| Overall Implementation Progress (IP) | Satisfactory | 2025-01-16 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Number of health facilities and laboratories provided with personal protective equipment under the project Value 0.00 228.00 228.00 Date April 30, 2020 June 18, 2022 June 30, 2021 Comment Percentage of priority populations vaccinated based on targets defined in national plan, total Value 0.00 54.00 50.00 Date February 1, 2021 June 18, 2022 March 31, 2025 Comment Percentange of priority populations vaccinated based on targets defined in national plan by gender Value 0.00 54.00 50.00 Date February 1, 2021 June 18, 2022 March 31, 2025 Comment Number of hospitals equipped with chronic case management equipment Value 0.00 0.00 25.00 Date May 3, 2022 June 18, 2022 June 30, 2023 Comment Number of hospitals with strengthened emergency care capacity Value 0.00 0.00 10.00 Date May 3, 2022 June 18, 2022 June 30, 2023 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Percentage of Project supported health facilities and laboratories confirming receipt of equipment within 14 days of in-country delivery of such equipment Value 0.00 100.00 100.00 Date April 30, 2020 June 18, 2022 June 30, 2021 Comment Functional National Coordinating Committee (or the engagement of an existing committee) for COVID-19 vaccine introduction is in place Value No committee with clear terms of reference, roles, Committee established and operational Committee established and operational Date February 1, 2021 June 18, 2022 March 31, 2025 Comment COVID-19 vaccine delivery strategies to reach identified target groups are defined and include women in hard to reach areas and frontline health workers Value No specific strategies defined Operational strategies defined to identify and del Operational strategy defined to identify and deliv Date February 1, 2021 June 18, 2022 March 31, 2025 Comment Percentage of people reached by messages and/or materials to explain the vaccination campaign, total Value 0.00 97.00 70.00 Date February 1, 2021 June 18, 2022 March 31, 2025 Comment Percentage of people reached by messages and/or materials to explain the vaccination campaign by gender Value 0.00 97.00 70.00 Date February 1, 2021 June 18, 2022 March 31, 2025 Comment Percentage of beneficiaries reporting that community engagement processes were effective (transparent, inclusive, responsive), total Value 0.00 39.00 70.00 Date February 1, 2021 June 18, 2022 March 31, 2025 Comment Percentage of beneficiaries reporting that community engagement processes were effective (transparent, inclusive, responsive), by gender Value 0.00 39.00 70.00 Date February 1, 2021 June 18, 2022 March 31, 2025 Comment Functional health management and information system to deploy the COVID-19 vaccine is in place, including identification, registration and follow up with recipients by gener age and locality Value No functional health management and information sy Information system for COVID-19 vaccine deployment Information system for COVID-19 vaccine deployment Date February 1, 2021 June 18, 2022 March 31, 2025 Comment Percentage of female community workers (as a share of total community workers) providing vaccine information compared to baseline Value 0.00 60.00 60.00 Date February 1, 2021 August 2, 2021 March 31, 2025 Comment Share of people agreeing with the importance of the vaccine, total Value 41.00 75.00 70.00 Date February 1, 2021 June 18, 2022 March 31, 2025 Comment Share of people agreeing with the importance of the vaccine, by gender Value 41.00 78.00 70.00 Date February 1, 2021 June 18, 2022 December 31, 2025 Comment Number of public laboratories with improved pathogens detection capacity Value 0.00 0.00 40.00 Date December 31, 2025 December 31, 2025 December 31, 2025 Comment